You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

CLINICAL TRIALS PROFILE FOR LEVOLEUCOVORIN CALCIUM


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for levoleucovorin calcium

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02047474 ↗ Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer Active, not recruiting National Cancer Institute (NCI) Phase 2 2014-03-25 This phase II trial studies how well combination chemotherapy before and after surgery works in treating patients with localized pancreatic cancer. Drugs used in chemotherapy, such as leucovorin calcium, fluorouracil, irinotecan hydrochloride, and oxaliplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving combination chemotherapy before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed. Giving these treatments after surgery may kill any tumor cells that remain after surgery.
NCT02047474 ↗ Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer Active, not recruiting Yale University Phase 2 2014-03-25 This phase II trial studies how well combination chemotherapy before and after surgery works in treating patients with localized pancreatic cancer. Drugs used in chemotherapy, such as leucovorin calcium, fluorouracil, irinotecan hydrochloride, and oxaliplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving combination chemotherapy before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed. Giving these treatments after surgery may kill any tumor cells that remain after surgery.
NCT04060017 ↗ Early Treatment of Language Impairment in Young Children With Autism Spectrum Disorder With Leucovorin Calcium Recruiting New York State Institute for Basic Research Phase 2 2020-09-22 The primary objective of this study is to evaluate the cognitive and behavioral effects of liquid leucovorin calcium on young children with autism spectrum disorder (ASD) and determine whether it improves language as well as the core and associated symptoms of ASD. The investigators will enroll 80 children across two sites, between the ages of 2.5 and 5 years, with confirmed ASD and known language delays or impairments. Participation will last approximately 26 weeks from screening to end of treatment.
NCT04060017 ↗ Early Treatment of Language Impairment in Young Children With Autism Spectrum Disorder With Leucovorin Calcium Recruiting State University of New York - Downstate Medical Center Phase 2 2020-09-22 The primary objective of this study is to evaluate the cognitive and behavioral effects of liquid leucovorin calcium on young children with autism spectrum disorder (ASD) and determine whether it improves language as well as the core and associated symptoms of ASD. The investigators will enroll 80 children across two sites, between the ages of 2.5 and 5 years, with confirmed ASD and known language delays or impairments. Participation will last approximately 26 weeks from screening to end of treatment.
NCT04060017 ↗ Early Treatment of Language Impairment in Young Children With Autism Spectrum Disorder With Leucovorin Calcium Recruiting United States Department of Defense Phase 2 2020-09-22 The primary objective of this study is to evaluate the cognitive and behavioral effects of liquid leucovorin calcium on young children with autism spectrum disorder (ASD) and determine whether it improves language as well as the core and associated symptoms of ASD. The investigators will enroll 80 children across two sites, between the ages of 2.5 and 5 years, with confirmed ASD and known language delays or impairments. Participation will last approximately 26 weeks from screening to end of treatment.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for levoleucovorin calcium

Condition Name

Condition Name for levoleucovorin calcium
Intervention Trials
Language Disorders 2
Autism Spectrum Disorder 2
Stage I Pancreatic Cancer 1
Stage IIA Pancreatic Cancer 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for levoleucovorin calcium
Intervention Trials
Language Disorders 2
Disease 2
Autistic Disorder 2
Autism Spectrum Disorder 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for levoleucovorin calcium

Trials by Country

Trials by Country for levoleucovorin calcium
Location Trials
United States 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for levoleucovorin calcium
Location Trials
New York 2
Arizona 2
Connecticut 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for levoleucovorin calcium

Clinical Trial Phase

Clinical Trial Phase for levoleucovorin calcium
Clinical Trial Phase Trials
Phase 2 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for levoleucovorin calcium
Clinical Trial Phase Trials
Recruiting 2
Active, not recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for levoleucovorin calcium

Sponsor Name

Sponsor Name for levoleucovorin calcium
Sponsor Trials
New York State Institute for Basic Research 2
State University of New York - Downstate Medical Center 2
University of Arizona 2
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for levoleucovorin calcium
Sponsor Trials
Other 10
NIH 1
U.S. Fed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.